These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16915258)

  • 1. More fizz at Pfizer?
    Nature; 2006 Aug; 442(7104):734. PubMed ID: 16915258
    [No Abstract]   [Full Text] [Related]  

  • 2. Pfizer breaks from merger mentality as others chase leads.
    Weaver J
    Nat Med; 2011 Jul; 17(7):761. PubMed ID: 21738140
    [No Abstract]   [Full Text] [Related]  

  • 3. Pfizer slashes R&D.
    Cressey D
    Nature; 2011 Feb; 470(7333):154. PubMed ID: 21307908
    [No Abstract]   [Full Text] [Related]  

  • 4. Pfizer swallows Wyeth, validates niche buster.
    Sheridan C
    Nat Biotechnol; 2009 Mar; 27(3):218-9. PubMed ID: 19270661
    [No Abstract]   [Full Text] [Related]  

  • 5. What shoulder and what art.
    Nat Rev Drug Discov; 2005 Dec; 4(12):943. PubMed ID: 16370069
    [No Abstract]   [Full Text] [Related]  

  • 6. Pfizer stakes a claim in plant cell-made biopharmaceuticals.
    Ratner M
    Nat Biotechnol; 2010 Feb; 28(2):107-8. PubMed ID: 20139928
    [No Abstract]   [Full Text] [Related]  

  • 7. Medical innovation and patent gridlock.
    James JS
    AIDS Treat News; 2005 May; (412):6-8. PubMed ID: 16050004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How should we support pharmaceutical innovation?
    Grootendorst P
    Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming the challenges in the pharma/biotech industry.
    Graul AI; Prous JR
    Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pfizer hires 'outsider' for insider top job.
    Marris E
    Nat Rev Drug Discov; 2006 Sep; 5(9):709. PubMed ID: 17001800
    [No Abstract]   [Full Text] [Related]  

  • 11. Trimmed down Chiron pitches cancer genomics.
    Hodgson J
    Nat Biotechnol; 1998 Dec; 16(13):1308. PubMed ID: 9853602
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug patent plan gets mixed reviews.
    Butler D
    Nature; 2009 Feb; 457(7233):1064. PubMed ID: 19256077
    [No Abstract]   [Full Text] [Related]  

  • 13. Experiments in social responsibility.
    Herrling P
    Nature; 2006 Jan; 439(7074):267-8. PubMed ID: 16421547
    [No Abstract]   [Full Text] [Related]  

  • 14. Patent threat in emerging economies shifts to biotech.
    Jayaranam K
    Nat Biotechnol; 2008 May; 26(5):481-3. PubMed ID: 18464760
    [No Abstract]   [Full Text] [Related]  

  • 15. Wherefore art thou Romeo?
    Cooper RD
    Curr Opin Investig Drugs; 2004 Aug; 5(8):797-8. PubMed ID: 15602802
    [No Abstract]   [Full Text] [Related]  

  • 16. Reinventing an industry.
    Mandavilli A
    Nature; 2007 Jan; 445(7124):138-9. PubMed ID: 17215817
    [No Abstract]   [Full Text] [Related]  

  • 17. Sales from licensed and acquired products to increase by 2013.
    Goodman M
    Nat Rev Drug Discov; 2009 Jun; 8(6):443. PubMed ID: 19483704
    [No Abstract]   [Full Text] [Related]  

  • 18. Ayurveda.
    Padma TV
    Nature; 2005 Jul; 436(7050):486. PubMed ID: 16049472
    [No Abstract]   [Full Text] [Related]  

  • 19. Break with tradition.
    Jayaraman KS
    Nature; 2006 Jul; 442(7101):342-3. PubMed ID: 16871181
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmaceutical Portfolio & Product Life Cycle Management--SMi's fourth annual conference. 29-30 June 2009, London, UK.
    Beecher N
    IDrugs; 2009 Sep; 12(9):558-60. PubMed ID: 19697274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.